Melio

    OverviewSuggest Edit

    Melio (also known as ANALYSIS AND DIAGNOSTICS HEALTHCARE) is a company that helps people take control of their health via blood testing. It provides a platform enabling users to buy test packages and get results reviewed by healthcare professionals. The company specializes in blood analysis with a focus on hormones, thyroid profile, vitamins, diabetes, and more.
    TypePrivate
    Founded2019
    Websitemelio.es

    Latest Updates

    Employees (est.) (Oct 2020)17(+31%)
    Cybersecurity ratingAMore

    Melio Financials and Metrics

    Summary Metrics

    Founding Date

    2019

    Melio Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    94/100

    SecurityScorecard logo

    Melio Online and Social Media Presence

    Embed Graph

    Melio News and Updates

    Melio raise $144m

    Melio, a New York-based B2B payments outfit focused on small businesses, has raised $144 million to fund a hiring spree.

    US fintech Melio has raised $80 million and says its payments volume surged 700% during the pandemic

    Summary List Placement   Business-to-business payments platform Melio has raised $80 million to make it easier for businesses to pay their suppliers. The new Series C funding, led by investment fund Coatue Management, brings Melio's total funding to $144 million, the company said. The company also …

    Melio Frequently Asked Questions

    • When was Melio founded?

      Melio was founded in 2019.

    • How many employees does Melio have?

      Melio has 17 employees.

    • Who are Melio competitors?

      Competitors of Melio include Celula, Medefer and Savonix.